Search Results
Prescient Therapeutics PTX-100 continues to exhibit excellent safety profile
Prescient Therapeutics (ASX: PTX) – Webinar Presentation
Prescient Therapeutics (ASX: PTX): PTX-100 targeted cell therapy briefing - 2 March 2023
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100
Prescient Therapeutics (ASX: PTX) Webcast | SNN Network
Prescient Therapeutics (ASX: PTX) Investor Briefing - 28 July 2022
Prescient Therapeutics (ASX: PTX) Investor Briefing - 14 September 2022
Share Cafe Webinar - Micro/Small Cap "Hidden Gems" Webinar
ShareCafe "Hidden Gems" Webinar - 14 August 2020
